President Emmerson Mnangagwa commissioned a US$27 million medical cannabis farm and processing plant built by Swiss Bioceuticals at Mount Hampden. Contemporary reporting said only fifteen of fifty-seven cannabis permits had been activated and described concern that some were being held for speculation. Later in 2022 the medicines regulator began accepting applications for hemp-based CBD products as complementary medicines.[1][2]
Listed for context. No score change is recorded for Zimbabwe here.
References
- The Exchange — Medicinal cannabis farming takes root as Zimbabwe starts licensing farmers (20 May 2022)archived
- Medicines Control Authority of Zimbabwe — 2022 Annual ReportPrinted pages 53–55 and 60: production licences, inspection findings and hemp-based CBD applicationsarchived
Checked. The date and the event were compared with a source that was read.